Sunday, July 26, 2020 4:22:54 PM
Why iBio Stock Could Soar 500% Above Its Current Levels
The potential strength of IBIO stock is backed by promising technology and a well-connected partner
The biotech company is partnering with the Infectious Disease Research Institute (IDRI), on its Covid-19 vaccine. IDRI is part of the University of Washington, whose modeling has been used by the White House and NIH to predict the spread of coronavirus. Notably, IDRI has also received funding from the Bill & Melinda Gates Foundation. And iBio is also collaborating with Beijing-based CC-Pharming, potentially giving iBio the inside track to provide a Covid-19 vaccine to China.
Well if 3s come around , please post quickly I will load some more too...$IBIO
The potential strength of IBIO stock is backed by promising technology and a well-connected partner
The biotech company is partnering with the Infectious Disease Research Institute (IDRI), on its Covid-19 vaccine. IDRI is part of the University of Washington, whose modeling has been used by the White House and NIH to predict the spread of coronavirus. Notably, IDRI has also received funding from the Bill & Melinda Gates Foundation. And iBio is also collaborating with Beijing-based CC-Pharming, potentially giving iBio the inside track to provide a Covid-19 vaccine to China.
Well if 3s come around , please post quickly I will load some more too...$IBIO
The real measure of your wealth is how much you’d be worth if you lost all your money.
Recent IBIO News
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/17/2026 09:13:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/08/2026 01:00:47 PM
- iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia • GlobeNewswire Inc. • 04/08/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 08:05:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 11:31:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 11:30:09 AM
- iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) • GlobeNewswire Inc. • 03/16/2026 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:04:38 AM
- iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss • GlobeNewswire Inc. • 03/09/2026 11:00:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/09/2026 04:15:16 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/06/2026 10:25:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2026 09:49:58 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/27/2026 09:23:59 PM
- iBio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/24/2026 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 11:19:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/10/2026 09:16:39 PM
- iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 02/10/2026 09:05:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/09/2026 10:29:54 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/30/2026 09:10:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 11:15:07 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/30/2026 02:29:29 AM
